The follow-up studies showed that CCL3/CCR5 contributed to increased numbers of macrophages and T-cells in the lungs of patients with COPD (Ravi et al., 2014; Costa et al., 2016). This evidence concerns the gene CCR5 and chronic obstructive pulmonary disease.